Medindia LOGIN REGISTER
Medindia

IBS (Irritable Bowel Syndrome) Shows No Efficacy to Vitamin D Supplementation

by Karishma Abhishek on Jul 31 2021 11:18 PM

People with IBS have deficient vitamin D levels. However, scientists have found that vitamin D supplementation among these patients may not improve their painful symptoms.

IBS (Irritable Bowel Syndrome) Shows No Efficacy to Vitamin D Supplementation
Painful IBS symptoms may not improve by vitamin D supplementation as per a study at the University of Sheffield, published in the European Journal of Nutrition.
However, it was noted that people with IBS have deficient vitamin D levels. This leads to an increased risk of suffering from fractures and osteoporosis in the long term.

IBS (Irritable Bowel Syndrome) is a chronic functional disorder of the gastrointestinal tract characterized by altered bowels movements.

It affects over 10% of the population, costing the NHS over £11 million per year. The common symptoms of IBS include stomach cramps, bloating, constipation, or diarrhea.

Vitamin D and IBS

The study team for the first time enrolled the IBS patients to assess whether vitamin D reduced the severity of their symptoms, and improved their quality of life. The participants were supplemented with the vitamin D3 oral spray over a 12-week trial.

It was found that there was neither difference in the symptom severity of IBS nor a reported change in the participants’ quality of life even after vitamin D supplementation.

Advertisement
“For some people living with severe IBS, low vitamin D levels may be attributable to changes in diet and lifestyle. Some may feel due to the severity of their symptoms that they limit their outdoor activities due to the anxiety their symptoms can cause, or alter their diet to avoid certain foods triggering their symptoms. Unfortunately, all of these coping mechanisms can be detrimental to overall health and wellbeing and reduce exposure to valuable sources of vitamin D”, says Lead-author Professor of Human Nutrition and Health at Newcastle University and Honorary Fellow at the University of Sheffield, Bernard Corfe.

The study thereby lays the path to explore new ways to diagnose, treat and understand the impact of IBS on the population.

Advertisement
Source-Medindia


Advertisement